Moreover, PTC596 induced significant cytotoxicity in MM cell lines regardless of bortezomib sensitivity or the status of TP53 gene mutations and deletions, which are closely related to shorter survival, poor response, and resistance to drugs in MM29. The gene discussed is TP53; the disease is Miyoshi myopathy.